Evidence map›Paper›PMID 41640868›Full record

ArticleWorld journal of gastroenterology2026

Early catheter-directed portal vein thrombolysis in myeloproliferative disorder-related diffuse mesenteric venous ischemia: A case report.

Ya-Chin Chiu, Wei-Chou Chang, Yu-Cheng Chiu

Abstract readCase Reports
In one paragraph

Article in World journal of gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ya-Chin ChiuDepartment of General Surgery, Tri-Service General Hospital, Taipei 114, Taiwan.
Wei-Chou ChangDepartment of Radiology, Tri-Service General Hospital, Taipei 114, Taiwan.
Yu-Cheng ChiuDepartment of Trauma and General Surgery, Tri-Service General Hospital, Taipei 114, Taiwan. agaukysr@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPortal vein thrombosis (PVT) is a rare condition and is often associated with cirrhosis, malignancy, or prothrombotic states. Currently, systemic anticoagulation is the standard to treat PVT. The role of alternative treatments are currently under investigation. In particular direct thrombolysis for the treatment of nonmalignant PVT is controversial due to the risk of bleeding. Here we have reported a case highlighting therapeutic considerations and outcomes of direct thrombolysis. CASE SUMMARY: A 67-year-old male without a prior history of cirrhosis or malignancy presented with acute abdominal pain and peritonitis. Contrast-enhanced computed tomography revealed complete thrombosis of the portal vein with extension into the superior mesenteric vein. These findings were consistent with impending mesenteric ischemia. Despite systemic anticoagulation the patient's symptoms progressed. Urgent catheter-directed thrombolysis

conclusionEarly low-dose catheter-directed thrombolysis provided a safe and effective treatment for a patient with noncirrhotic, nonmalignant PVT associated with mesenteric ischemia, demonstrating the utility of an alternative treatment for PVT.

Indexed as

Fibrinolytic AgentsMesenteric IschemiaMyeloproliferative DisordersPolycythemia VeraPortal VeinThrombolytic TherapyUrokinase-Type Plasminogen ActivatorVenous ThrombosisAbdominal PainAgedHumansJanus Kinase 2MaleMesenteric VeinsPeritonitisTomography, X-Ray ComputedFibrinolytic AgentsJAK2 protein, humanJanus Kinase 2Urokinase-Type Plasminogen ActivatorCase reportCatheter-directed thrombolysisMyeloproliferative disorderPortal vein thrombosisTranshepatic thrombolysisTransjugular thrombolysis

Identifiers

PMID41640868
PMCPMC12865400

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.